411 related articles for article (PubMed ID: 36982351)
1. Dialog beyond the Grave: Necrosis in the Tumor Microenvironment and Its Contribution to Tumor Growth.
Zapletal E; Vasiljevic T; Busson P; Matijevic Glavan T
Int J Mol Sci; 2023 Mar; 24(6):. PubMed ID: 36982351
[TBL] [Abstract][Full Text] [Related]
2. Toll-Like Receptors (TLRs) in the Tumor Microenvironment (TME): A Dragon-Like Weapon in a Non-fantasy Game of Thrones.
Angrini M; Varthaman A; Cremer I
Adv Exp Med Biol; 2020; 1263():145-173. PubMed ID: 32588327
[TBL] [Abstract][Full Text] [Related]
3. Toll-Like Receptors Signaling in the Tumor Microenvironment.
McCall KD; Muccioli M; Benencia F
Adv Exp Med Biol; 2020; 1223():81-97. PubMed ID: 32030686
[TBL] [Abstract][Full Text] [Related]
4. Interactions between tumor-derived proteins and Toll-like receptors.
Jang GY; Lee JW; Kim YS; Lee SE; Han HD; Hong KJ; Kang TH; Park YM
Exp Mol Med; 2020 Dec; 52(12):1926-1935. PubMed ID: 33299138
[TBL] [Abstract][Full Text] [Related]
5. Human mesenchymal stem cells respond to native but not oxidized damage associated molecular pattern molecules from necrotic (tumor) material.
Lotfi R; Eisenbacher J; Solgi G; Fuchs K; Yildiz T; Nienhaus C; Rojewski MT; Schrezenmeier H
Eur J Immunol; 2011 Jul; 41(7):2021-8. PubMed ID: 21538978
[TBL] [Abstract][Full Text] [Related]
6. Damage-associated molecular patterns and Toll-like receptors in the tumor immune microenvironment.
Yanai H; Hangai S; Taniguchi T
Int Immunol; 2021 Nov; 33(12):841-846. PubMed ID: 34357403
[TBL] [Abstract][Full Text] [Related]
7. Extracellular Vesicles and DAMPs in Cancer: A Mini-Review.
Abu N; Rus Bakarurraini NAA; Nasir SN
Front Immunol; 2021; 12():740548. PubMed ID: 34721407
[TBL] [Abstract][Full Text] [Related]
8. Necrotic Cells from Head and Neck Carcinomas Release Biomolecules That Are Activating Toll-like Receptor 3.
Vasiljevic T; Tarle M; Hat K; Luksic I; Mikulandra M; Busson P; Matijevic Glavan T
Int J Mol Sci; 2023 Oct; 24(20):. PubMed ID: 37894949
[TBL] [Abstract][Full Text] [Related]
9. DAMP-TLR-cytokine axis dictates the fate of tumor.
Patidar A; Selvaraj S; Sarode A; Chauhan P; Chattopadhyay D; Saha B
Cytokine; 2018 Apr; 104():114-123. PubMed ID: 29032985
[TBL] [Abstract][Full Text] [Related]
10. RAGE and TLRs: relatives, friends or neighbours?
Ibrahim ZA; Armour CL; Phipps S; Sukkar MB
Mol Immunol; 2013 Dec; 56(4):739-44. PubMed ID: 23954397
[TBL] [Abstract][Full Text] [Related]
11. Damage-associated molecular patterns (DAMPs) and mesenchymal stem cells: a matter of attraction and excitement.
Pistoia V; Raffaghello L
Eur J Immunol; 2011 Jul; 41(7):1828-31. PubMed ID: 21706488
[TBL] [Abstract][Full Text] [Related]
12. TLR-mediated metabolic reprogramming in the tumor microenvironment: potential novel strategies for cancer immunotherapy.
Huang L; Xu H; Peng G
Cell Mol Immunol; 2018 May; 15(5):428-437. PubMed ID: 29553135
[TBL] [Abstract][Full Text] [Related]
13. Toll-Like Receptors (TLRs), NOD-Like Receptors (NLRs), and RIG-I-Like Receptors (RLRs) in Innate Immunity. TLRs, NLRs, and RLRs Ligands as Immunotherapeutic Agents for Hematopoietic Diseases.
Wicherska-Pawłowska K; Wróbel T; Rybka J
Int J Mol Sci; 2021 Dec; 22(24):. PubMed ID: 34948194
[TBL] [Abstract][Full Text] [Related]
14. The Yin and Yang of Toll-like receptors in cancer.
Pradere JP; Dapito DH; Schwabe RF
Oncogene; 2014 Jul; 33(27):3485-95. PubMed ID: 23934186
[TBL] [Abstract][Full Text] [Related]
15. Damage-Associated Molecular Patterns in the Course of Lung Cancer--A Review.
Łagiedo M; Sikora J; Kaczmarek M
Scand J Immunol; 2015 Aug; 82(2):95-101. PubMed ID: 25966741
[TBL] [Abstract][Full Text] [Related]
16. TLR signaling by tumor and immune cells: a double-edged sword.
Huang B; Zhao J; Unkeless JC; Feng ZH; Xiong H
Oncogene; 2008 Jan; 27(2):218-24. PubMed ID: 18176603
[TBL] [Abstract][Full Text] [Related]
17. Toll-like receptor--a potent driving force behind rheumatoid arthritis.
Takagi M
J Clin Exp Hematop; 2011; 51(2):77-92. PubMed ID: 22104306
[TBL] [Abstract][Full Text] [Related]
18. Toll-like receptor stimulation in cancer: A pro- and anti-tumor double-edged sword.
Dajon M; Iribarren K; Cremer I
Immunobiology; 2017 Jan; 222(1):89-100. PubMed ID: 27349597
[TBL] [Abstract][Full Text] [Related]
19. The role of toll-like receptors (TLRs) in pan-cancer.
Huang R; Sun Z; Xian S; Song D; Chang Z; Yan P; Zhang J; Yin H; Zheng Z; Hu P; Li Z; Huang D; Liu Y; Jiang C; Li M; Li S; Meng T; Yang D; Huang Z
Ann Med; 2022 Dec; 54(1):1918-1937. PubMed ID: 35801728
[TBL] [Abstract][Full Text] [Related]
20. Roles of toll-like receptors in cancer: a double-edged sword for defense and offense.
Basith S; Manavalan B; Yoo TH; Kim SG; Choi S
Arch Pharm Res; 2012 Aug; 35(8):1297-316. PubMed ID: 22941474
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
